Sanara Medtech Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -134.2% | – | -882.1% | – | – | – | – | – | – | |
| – | +6.4% | +1.4% | +32.5% | +4.0% | +43.0% | +142.9% | +104.9% | +297.2% | +55.0% | +34.0% | +480.1% | |
| – | -91.7% | +1,725.7% | -92.6% | -75.3% | – | – | +90.2% | +1.3% | +27.4% | +28.9% | -83.8% | |
| – | – | +162.8% | -119.6% | – | +338.1% | +236.3% | +184.7% | -117.2% | – | – | – | |
| – | – | – | – | – | -80.0% | -934.6% | – | – | -733.5% | – | – | |
| – | -33.9% | -43.2% | +2,735.1% | -90.1% | +20,005.0% | -3.6% | -54.4% | -0.5% | -64.5% | -13.6% | +1,917.3% | |
| – | -36.9% | -43.2% | +2,735.1% | -90.1% | +14,013.4% | +129.3% | +92.6% | -33.6% | +190.7% | -35.2% | +26.5% | |
| – | – | – | -29.6% | +586.6% | +4,381.6% | -94.2% | -24.1% | -50.3% | – | – | – | |
| – | – | – | -106.2% | – | – | – | -1,225.2% | – | – | – | – | |
| – | – | -275.1% | -5.1% | – | +0.0% | +0.0% | -100.0% | – | – | +102.2% | -47.1% | |
| – | -60.1% | -71.8% | -159.0% | +44.0% | – | -93.6% | +4,446.9% | -102.2% | – | +80.1% | -148.8% | |
| – | -171.2% | – | -156.9% | – | +2,295.4% | -195.7% | – | -153.3% | – | – | -193.5% | |
| – | – | – | -155.6% | – | -1,541.5% | – | – | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.